AC Immune SA (ACIU)
3.21
-0.20
(-5.87%)
USD |
NASDAQ |
May 17, 16:00
3.21
0.00 (0.00%)
After-Hours: 16:35
AC Immune Market Cap: 317.47M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 337.25M |
| May 15, 2024 | 347.14M |
| May 14, 2024 | 354.06M |
| May 13, 2024 | 326.37M |
| May 10, 2024 | 228.46M |
| May 09, 2024 | 232.41M |
| May 08, 2024 | 232.41M |
| May 07, 2024 | 235.38M |
| May 06, 2024 | 237.36M |
| May 03, 2024 | 236.37M |
| May 02, 2024 | 241.31M |
| May 01, 2024 | 247.25M |
| April 30, 2024 | 245.27M |
| April 29, 2024 | 237.36M |
| April 26, 2024 | 232.41M |
| April 25, 2024 | 226.48M |
| April 24, 2024 | 234.39M |
| April 23, 2024 | 235.38M |
| April 22, 2024 | 239.34M |
| April 19, 2024 | 233.40M |
| April 18, 2024 | 235.38M |
| April 17, 2024 | 239.34M |
| April 16, 2024 | 242.30M |
| April 15, 2024 | 249.23M |
| April 12, 2024 | 270.98M |
| Date | Value |
|---|---|
| April 11, 2024 | 269.99M |
| April 10, 2024 | 276.92M |
| April 09, 2024 | 276.92M |
| April 08, 2024 | 276.92M |
| April 05, 2024 | 271.97M |
| April 04, 2024 | 271.97M |
| April 03, 2024 | 276.92M |
| April 02, 2024 | 267.03M |
| April 01, 2024 | 269.99M |
| March 28, 2024 | 292.74M |
| March 27, 2024 | 299.66M |
| March 26, 2024 | 280.87M |
| March 25, 2024 | 286.81M |
| March 22, 2024 | 303.62M |
| March 21, 2024 | 311.53M |
| March 20, 2024 | 321.92M |
| March 19, 2024 | 332.30M |
| March 18, 2024 | 346.15M |
| March 15, 2024 | 346.15M |
| March 14, 2024 | 329.33M |
| March 13, 2024 | 367.03M |
| March 12, 2024 | 347.19M |
| March 11, 2024 | 339.26M |
| March 08, 2024 | 374.97M |
| March 07, 2024 | 384.89M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
143.47M
Minimum
Dec 22 2022
710.69M
Maximum
Jan 15 2020
372.63M
Average
358.42M
Median
Market Cap Benchmarks
| CRISPR Therapeutics AG | 4.772B |
| Addex Therapeutics Ltd | 9.384M |
| NLS Pharmaceutics Ltd | 6.641M |
| Molecular Partners AG | 127.15M |
| MoonLake Immunotherapeutics | 2.499B |
Market Cap Related Metrics
| Price to Book Value | 1.980 |
| Price | 3.21 |
| Earnings Yield | -21.46% |